Study uncovers a process in cells that may limit infectivity of SARS-CoV-2
Scientists at the National Institutes of Health have found that a process in cells may
SARS
Hypertonic saline solution shown to inhibit replication of SARS-CoV-2
Researchers at the University of São Paulo (USP) in Brazil have shown that a hypertonic
Gorillas at Atlanta Zoo have been infected by SARS-CoV-2
The coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues
SARS CoV-2 antibodies in breast milk: Study
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that caused the coronavirus disease
Vaccination against SARS-CoV-2 with a single dose skin patch
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel betacoronavirus that emerged in Wuhan, China,
SARS-CoV-2 virus persistence in immunocompromised individuals
Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests are frequently obtained from individuals that
Previously infected vaccinees broadly neutralize SARS-CoV-2 variants of concern
Researchers in the United States have conducted a study demonstrating the effectiveness of first-generation vaccines
Study reveals a hidden role of circulating microRNA as a driver of SARS-CoV-2 infection
In a methodological tour-de-force study, a large group of researchers from the USA and the
Sinovac COVID-19 vaccine shows 50% effectiveness in a cohort of Brazilian healthcare workers
CoronaVac is a well-tolerated vaccine containing inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and
Supercomputer simulations illuminate the behavior of dominant G form of SARS-CoV-2
Large-scale supercomputer simulations at the atomic level show that the dominant G form variant of